NHI Paid $555 Million to Become an Operator, Then Found Out Operating Is Hard
The trade is executed; the machine is not yet running
National Health Investors spent the better part of two years telling investors a simple story: sell the skilled-nursing exposure, recycle the cash into private-pay senior housing, and capture the operating upside directly through SHOP. On the strategic front, management delivered. The NHC portfolio closed on July 1 for $555 million of net proceeds, more than $395 million has already been redeployed this year at a 7.5% average yield, and SHOP is now roughly 18% of NOI versus 9% entering the year.
Then came the operating part. Eric Mendelsohn did not soften it: “our third quarter SHOP performance fell short of our expectations. Our 15 same-store properties delivered approximately 19.5% year-over-year NOI growth, consistent with our outlook, but recent performance in the non-same-store communities reduced the contribution we expected from the total portfolio in the quarter.” — D. Mendelsohn, President and CEO · 2026-11-10 That is the whole tension of this report in two sentences. The NOI growth that the legacy pool was supposed to deliver showed up. The newly acquired buildings — the entire point of the pivot — dragged.
The consequence was mechanical. Full-year NAREIT and normalized FFO guidance moved to $4.68–$4.70, with funds available for distribution cut $5 million at the midpoint, driven by $2.3 million of lower SHOP NOI across the 42 properties in the portfolio and $2.8 million of additional recurring CapEx. Trailing funds from operations of $53 million was up 15% year over year yet down 7% sequentially — a fair picture of a company that grew its asset base faster than its earnings base.
What actually broke: transitions, incentives, vacant units
New COO Chris Maingot, on his first NHI call, did the useful thing and separated the miss into buckets rather than hiding behind "seasonality." The acquisitions involved operator transitions — “we saw some pretty local mom-and-pop type family businesses being sold to more sophisticated incoming operators. And with that, there's a level of complexity as you introduce new technologies and so forth. So the pickup there was a little slower than we expected.” — Christian Maingot, Chief Operating Officer · 2026-11-10 In one portfolio, incoming occupancy was below the assumed starting point; in another, immediate move-outs.
The remediation reads like a classic sales-force triage: staffed sales positions, rent-ready vacant units, locally calibrated pricing and concessions, plus short-term incentives for community teams. Maingot noted the early read: “we have seen an uptick in our occupancy in August, September and October.” — Christian Maingot, Chief Operating Officer · 2026-11-10 Encouraging, but he immediately flagged that holiday-season tapering and move-in incentives may mute the financial benefit — in other words, occupancy up, NOI later.
The CapEx was the second surprise. Mendelsohn conceded the spend is above what was underwritten and reframed it in operator language: “We've been putting a lot of CapEx in our SHOP buildings that are what I call stealth improvements, new roofing, new boilers. Nobody sees that when they're touring a building. They want to see new furniture, new carpet. They want that new building smell.” — D. Mendelsohn, President and CEO · 2026-11-10 Investors heard it as cost. The company is calling it stealth improvements that were not budgeted — a candid admission that the diligence on older assets understated the refresh required to compete for tours.
The deal NHI chose not to do — and the ones it will let go
The most interesting new disclosure was negative. NHI booked $1.1 million of transaction costs and about $1 million of legal expense on a large SHOP transaction it walked away from: “we got to a point in our diligence and our contract negotiations that we felt that the terms were out of market. So we made our best and final offer, and we had to walk away.” — D. Mendelsohn, President and CEO · 2026-11-10 After a year of rhetoric about large portfolios and a $285 million signed-LOI pipeline, that is a discipline signal — and a reminder that the good deals are being bid away by better-capitalized operating buyers.
On the other side of the ledger, Kevin Pascoe is now marketing the lingering issues inside the same-store pool: “We're looking at proceeds that would be north of $100 million should we elect to sell.” — Kevin Pascoe, Chief Investment Officer · 2026-11-10 Pruning the laggards is the right capital-allocation answer, but it also means the same-store pool that just printed 19.5% growth is not a permanent, growing base — it gets re-engineered every few quarters.
A promise that keeps getting re-based
This is where prior calls matter. In November 2025, Kevin Pascoe was already defending a soft patch by pointing backward:
In the same call the same-store SHOP guidance was reset from 13%–16% to 7%–9%. In February, the framing was “It is a bit of an under-promise, over-deliver.” — Kevin Carlton Pascoe, Chief Investment Officer · 2026-02-27 Now the target is "high single-digit to low double-digit" organic SHOP performance, with management explicitly acknowledging the results will be the measure. Each individual reset was defensible; stacked together they show a company that has repeatedly underwritten more operating lift than its partners delivered.I would say we also telegraphed this last quarter that we saw... we knew that the third quarter was going to be softer than the second because of the things that we were seeing in the portfolio. So I don't think it crept up on us. I think it was a matter of -- we saw it coming. We telegraphed it.
The structural fix is real, at least: the asset management team has been split into dedicated SHOP and triple-net/loan groups, and a beefed-up analytics team is meant to catch underperformance earlier. Mendelsohn puts hiring at "75% to 80% there." The question is whether a data layer fixes a problem whose root cause was buying assets run by owner-operators who were then replaced.
The tape disagrees with the strategy — for now
NHI's shares sit 25.5% below the February 17 peak of $91.02 and are down 12.3% over the last ninety trading days, a steady one-way slide with no bounce. Meanwhile the operators and healthcare-facility names in the adjacent tape have been bid: the De Novo facility cluster — ACHC, RDNT, SGRY — has rallied 22%–32% over the past month, and healthcare-facility reporters keep citing De Novo growth plans. The market is paying for capacity and operating leverage while penalizing the landlord that just bought its way into operations and missed the first quarter.
Balance sheet is not the problem: net debt to adjusted EBITDA was 3.6x reported, 2.4x adjusting for the $340 million held for 1031 exchanges, with roughly $1 billion of liquidity and no maturities until 2028 after the January 2027 note is repaid. Interest coverage of 3.0x, however, has been trending down, and liabilities at 46.4% of assets leave room to keep buying. At 22.1x trailing earnings, the stock is neither a bargain nor a warning.
So the read is this: NHI has completed the financial engineering and is now in the unglamorous part — proving it can run what it bought. The tape is pricing doubt, not disaster. The next two quarters of occupancy, and whether the 2027 budgets deliver the promised high-single-digit growth, will decide whether this was a transitional year or a repricing of the whole SHOP thesis.